Glucose Monitoring Devices Market Size to Hit US$ 23.19 Billion by 2031 | Growth Plus Reports

Newark, New Castle, USA, June 01, 2023 (GLOBE NEWSWIRE) -- The market analysis of the global glucose monitoring devices market was conducted by Growth Plus Reports in 2022 and is valued at US$ 12.72 billion. The market is expected to hit a revenue CAGR of 7.8% to reach US$ 23.19 billion by 2031.

Analysis of the global market for glucose monitoring devices indicates that during the forecast period, revenue share is likely to increase significantly.

The incidence of diabetes, technological improvements, and the rising need for simple and reliable glucose monitoring solutions are all contributing to the considerable rise of the global market for glucose monitoring devices. Glucose monitoring devices play a crucial role in the management of diabetes by providing real-time blood glucose level measurements. The market is poised for substantial expansion in the coming years, presenting lucrative opportunities for industry players.

Request a Free Sample PDF:

                                   Glucose Monitoring Devices Market Scope

Report AttributeDetails
Market Size Value in 2022US$ 12.72 billion
Revenue Forecast in 2031US$ 23.19 billion
Base Year for Estimation2022
Forecast Period2023 to 2031
Historical Year2021
Segments CoveredProduct, End User, and Region
Regional ScopeNorth America, Europe, Asia Pacific, Latin America, and the Middle East & Africa

Globally, the incidence of diabetes is increasing due to factors including sedentary lifestyles, poor eating habits, and an aging population. 

As a result, the demand for glucose monitoring devices has witnessed a significant upsurge. These devices are essential for individuals with diabetes to monitor their blood glucose levels regularly, make informed decisions regarding medication, diet, and exercise, and maintain optimal glycemic control.

One of the key factors driving the revenue is the continuous advancements in technology. Manufacturers are introducing innovative glucose monitoring devices with improved accuracy, convenience, and connectivity features. Continuous glucose monitoring (CGM) systems have gained traction in recent years. CGM systems provide real-time glucose readings, alerts for high or low glucose levels, and valuable trend data, enabling individuals with diabetes to make timely adjustments to their management plans.

Moreover, the increasing adoption of wearable and non-invasive glucose monitoring devices is another significant trend in the market. These devices eliminate the need for fingerstick testing, offering a less invasive and more convenient monitoring experience. Continuous research and development studies and efforts are focused on developing wearable sensors and smart contact lenses that can measure glucose levels through tears or sweat, providing individuals with diabetes with a more seamless and hassle-free monitoring solution.

In addition to technological advancements, the market growth is also driven by the growing awareness of the importance of regular glucose monitoring and the need for better diabetes management. Governments, healthcare organizations, and patient advocacy groups are actively involved in initiatives to raise awareness about diabetes and promote early diagnosis and effective monitoring. This heightened awareness, coupled with the increasing prevalence of diabetes, contributes to the demand for glucose-monitoring devices.

Request for Customization –

Recent Development in the Glucose Monitoring Devices Market: 

  • In February 2023, the newest Dexcom G7 CGM System will be covered for Medicare enrollees, according to a statement from Dexcom, Inc. Dexcom G7 will be available to all Medicare patients with diabetes who fulfill the eligibility requirements as it satisfies the category requirements for therapeutic CGM systems established by the U.S. Centers for Medicare & Medicaid Services. The CGM attaches to the back of the upper arm or, if pediatric patients desire, the upper buttocks. It transmits glucose readings to a Dexcom receiver or a smart device that is compatible with it. 

Competitive Landscape

A list of the prominent players operating in the global market for glucose monitoring devices includes: 

  • F. Hoffmann-La Roche Ltd
  • DexCom, Inc.
  • Abbott Laboratories
  • LifeScan, Inc.
  • Insulet Corporation

Market Segmentation: 

Based on products, the global glucose monitoring devices market is segmented into self-monitoring devices, glucose meters, testing strips, lancets, sensors, transmitters & receivers, insulin pumps, and continuous glucose monitoring devices. 

Self-monitoring glucose monitoring equipment is simple to use and doesn't need any instruction. Patients now have more convenience and flexibility since they can check their blood glucose levels at home or while they're on the road.

Based on end-user, the global hospitals, home care, and diagnostic centers. 

Diabetes is quite common in North America and has been slowly becoming worse in recent years. There is now a sizable patient population as a result.

Table of Content

    1. Market Ecosystem
    2. Timeline Under Consideration
      1. Historical Years – 2021
      2. Base Year – 2022
      3. Forecast Years – 2023 to 2031
    3. Currency Used in the Report
    1. Research Approach
    2. Data Collection Methodology
    3. Data Sources
      1. Secondary Sources 
      2. Primary Sources
    4. Market Estimation Approach
      1. Bottom Up
      2. Top Down 
    5. Market Forecasting Model
    6. Limitations and Assumptions
    1. Current Market Trends (COVID-19 Perspective)
    2. Key Players & Competitive Positioning (2022) 
    3. Regulatory Landscape
    4. Reimbursement Sicario 
    1. Drivers
    2. Restraints/Challenges
    3. Opportunities
    1. Self-monitoring Devices
      1. Glucose Meters
      2. Testing Strips
      3. Lancets
    2. Continuous Glucose Monitoring Devices
      1. Sensors
      2. Transmitters & Receivers
      3. Insulin Pumps
    1. Hospitals
    2. Home Care
    3. Diagnostic Centers


Buy this Premium Research Report:


  • Powered with Complimentary Analyst Hours and Expert Interviews with Each Report
  • Comprehensive quantitative and qualitative insights at segment and sub-segment level
  • Covid 19 impact trends and perspective
  • Granular insights at global/regional/country level
  • Deep-rooted insights on market dynamics (drivers, restraints, opportunities) and business environment
  • Blanket coverage on competitive landscape
  • Winning imperatives
  • Exhaustive coverage on 'Strategic Developments' registered by leading players of the market.


  • Distributor Landscape Assessment
  • Pricing Intelligence
  • Customer Base Assessment
  • Investment & Initiatives Analysis
  • 'Business Profile' of Key Players

Schedule a call with our analyst:

Visit our report store at -

Browse more latest healthcare reports:

Medical Device Analytical Testing Outsourcing Market by Service (Material Characterization, Extractable and Leachable), Application (Cardiology, Diabetes Care), End User (Hospitals, Homecare Setting)– Global Outlook & Forecast 2023-2031

Differentiated Thyroid Cancer Therapeutics Market by Therapy (Thyroid Stimulating Hormone Suppression, Chemotherapy), End User (Hospitals, Oncology Centers) – Global Outlook & Forecast 2023-2031

Medicated Feed Additives Market by Animal Type (Ruminants, Swine, Poultry), Type (Antibiotics, Vitamins, Antioxidants), Mixture Type (Supplements, Concentrates)– Global Outlook & Forecast 2023-2031

Rare Neurological Disease Treatment Market by Drug Type (Biologics, Small Molecules), Indication (Narcolepsy, Creutzfeldt-Jakob Disease, Multiple Sclerosis), Distribution Channel (Hospital Pharmacies, Retail Pharmacies)– Global Outlook & Forecast 2023-2031

Phototherapy Lamps and Units for Aesthetic Medicine Market by Modality (Fixed Units, Mobile Units), Source (Infrared Light, UV Light), End User (Skincare & Cosmetic Clinics, Hospitals)– Global Outlook & Forecast 2023-2031

Unleashing the Power of Innovation in Med Tech

About Us:

Growth Plus Reports is part of GRG Health, a global healthcare knowledge service company. We are proud members of EPhMRA (European Pharmaceutical Marketing Research Association).

Growth Plus portfolio of services draws on our core capabilities of secondary & primary research, market modelling & forecasting, benchmarking, analysis and strategy formulation to help clients create scalable, ground-breaking solutions that prepare them for future growth and success.

We were awarded by the prestigious CEO Magazine as "Most Innovative Healthcare Market Research Company in 2020.